Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m

NCT05141708 · clinicaltrials.gov ↗

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Breast Neoplasms

Interventions

DRUG: Talazoparib

Sponsor

Pfizer